Insider · CIK 0001816952

Karydas Daphne

Reports to the SEC for 5 companies · RADNOR, PA

sec.gov

Transactions

Companies

Filings

CIK

0001816952

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$12.02	+$36.1K	9,200
2026-09-15	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	35,000
2026-09-15	MLYSMineralys Therapeutics, Inc.S Sale	Director	SSale	−3,000 sh	$28.58	−$85.7K	6,200
2026-06-17	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	38,000
2026-06-17	MLYSMineralys Therapeutics, Inc.S Sale	Director	SSale	−3,000 sh	$25.00	−$75K	6,200
2026-06-17	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$12.02	+$36.1K	9,200
2026-05-27	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+21.1K sh	—	—	21,110
2026-03-31	MLYSMineralys Therapeutics, Inc.S Sale	Director	SSale	−3,000 sh	$25.00	−$75K	6,200
2026-03-31	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	41,000
2026-03-31	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$12.02	+$36.1K	9,200
2026-02-19	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+8,300 sh	—	—	8,300
2026-02-19	MLYSMineralys Therapeutics, Inc.A Award	Director	AAward	+6,200 sh	—	—	6,200
2025-11-13	MLYSMineralys Therapeutics, Inc.S Sale	Director	SSale	−4,885 sh	$46.36	−$226K	0
2025-11-13	MLYSMineralys Therapeutics, Inc.S Sale	Director	SSale	−10.1K sh	$45.81	−$463K	4,885
2025-11-13	MLYSMineralys Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$10.20	+$153K	15,000
2025-11-13	MLYSMineralys Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	17,900
2025-06-12	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2025-02-13	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+32.9K sh	—	—	32,900
2024-05-22	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+22K sh	—	—	22,000
2024-05-09	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-09-18	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+52K sh	—	—	52,000
2023-09-13	MLYSMineralys Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+44K sh	—	—	44,000
2022-11-16	LogicBio Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2022-06-17	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-06-11	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-02-03	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+95K sh	—	—	95,000
2020-12-10	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Sep 174
Karydas Daphne0001816952-26-000005
SEC(opens sec.gov)
Jun 174
Karydas Daphne0001933414-26-000093
SEC(opens sec.gov)
May 294
Karydas Daphne0001816952-26-000004
SEC(opens sec.gov)
Apr 24
Karydas Daphne0001816952-26-000002
SEC(opens sec.gov)
Feb 204
Karydas Daphne0001933414-26-000042
SEC(opens sec.gov)
Nov 134
Karydas Daphne0001933414-25-000150
SEC(opens sec.gov)
Jun 134
Karydas Daphne0001816590-25-000071
SEC(opens sec.gov)
Feb 244
Karydas Daphne0001933414-25-000013
SEC(opens sec.gov)
May 234
Karydas Daphne0001933414-24-000020
SEC(opens sec.gov)
May 134
Karydas Daphne0001816590-24-000095
SEC(opens sec.gov)

Companies

Address

150 N. RADNOR CHESTER RD. SUITE F200

RADNOR, PA, 19087